IL82806A - Sustained release capsules containing mixture of drug,polyvinyl pyrrolidone and carboxyvinyl polymer - Google Patents

Sustained release capsules containing mixture of drug,polyvinyl pyrrolidone and carboxyvinyl polymer

Info

Publication number
IL82806A
IL82806A IL82806A IL8280687A IL82806A IL 82806 A IL82806 A IL 82806A IL 82806 A IL82806 A IL 82806A IL 8280687 A IL8280687 A IL 8280687A IL 82806 A IL82806 A IL 82806A
Authority
IL
Israel
Prior art keywords
drug
sustained release
polyvinyl pyrrolidone
carboxyvinyl polymer
capsules containing
Prior art date
Application number
IL82806A
Other languages
English (en)
Other versions
IL82806A0 (en
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Publication of IL82806A0 publication Critical patent/IL82806A0/xx
Publication of IL82806A publication Critical patent/IL82806A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
IL82806A 1986-06-16 1987-06-08 Sustained release capsules containing mixture of drug,polyvinyl pyrrolidone and carboxyvinyl polymer IL82806A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/874,732 US4798725A (en) 1986-06-16 1986-06-16 Sustained release capsule

Publications (2)

Publication Number Publication Date
IL82806A0 IL82806A0 (en) 1987-12-20
IL82806A true IL82806A (en) 1990-11-29

Family

ID=25364440

Family Applications (1)

Application Number Title Priority Date Filing Date
IL82806A IL82806A (en) 1986-06-16 1987-06-08 Sustained release capsules containing mixture of drug,polyvinyl pyrrolidone and carboxyvinyl polymer

Country Status (13)

Country Link
US (1) US4798725A (ja)
EP (1) EP0250038B1 (ja)
JP (1) JPH0830007B2 (ja)
AT (1) AT398165B (ja)
AU (1) AU589866B2 (ja)
CA (1) CA1295247C (ja)
DE (1) DE3772269D1 (ja)
DK (1) DK306587A (ja)
IE (1) IE60586B1 (ja)
IL (1) IL82806A (ja)
NZ (1) NZ220696A (ja)
PH (1) PH25179A (ja)
ZA (1) ZA874315B (ja)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772473A (en) * 1986-06-16 1988-09-20 Norwich Eaton Pharmaceuticals, Inc. Nitrofurantoin dosage form
NL8701335A (nl) * 1986-06-21 1988-01-18 Sandoz Ag Orale farmaceutische preparaten.
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US5178880A (en) * 1989-07-25 1993-01-12 Norwich Eaton Pharmaceuticals, Inc. Liquid suspensions of nitrofurantoin
US5332832A (en) * 1989-07-26 1994-07-26 Procter & Gamble Pharmaceuticals, Inc. Nitrofurantoin crystals
JPH03145418A (ja) * 1989-10-27 1991-06-20 Sumitomo Pharmaceut Co Ltd 塩基性薬物塩酸塩の徐放性製剤
US5431916A (en) * 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5484607A (en) * 1993-10-13 1996-01-16 Horacek; H. Joseph Extended release clonidine formulation
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
EP0862419B2 (en) 1995-11-09 2010-11-17 Microbiological Research Authority Microencapsulated dna for vaccination and gene therapy
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
IN186245B (ja) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US8524277B2 (en) * 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
GB9810236D0 (en) 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents
US6406719B1 (en) 1998-05-13 2002-06-18 Microbiological Research Authority Encapsulation of bioactive agents
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
KR20010099975A (ko) * 1998-12-28 2001-11-09 우에하라 아끼라 외용제
US6383515B2 (en) 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6372252B1 (en) 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
ES2196948B1 (es) * 2001-03-29 2005-02-01 Easyblind, S.L. Persiana enrollable perfeccionada.
US20030012820A1 (en) * 2001-06-12 2003-01-16 Upadhyay Ajay Hasmukhlal Compressible guaifenesin compositions, method for making same and method for making compressed guaifenesin dosage forms therefrom
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
US20030203055A1 (en) * 2002-03-15 2003-10-30 Cypress Bioscience, Inc. Methods of treating visceral pain syndromes
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
US20060222713A1 (en) * 2002-12-16 2006-10-05 Deepak Murpani Extended release pharmaceutical composition of phenytoin sodium
WO2004067039A1 (en) * 2003-01-28 2004-08-12 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US20050152967A1 (en) * 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
CN101277699B (zh) * 2005-08-23 2011-01-12 日产化学工业株式会社 缓释制剂
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
JP4926495B2 (ja) * 2006-02-22 2012-05-09 興和株式会社 イブプロフェン含有コーティング顆粒
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
CA2689978A1 (en) * 2007-06-08 2008-12-18 Addrenex Pharmaceuticals, Inc. Extended release formulation and method of treating adrenergic dysregulation
US20100172991A1 (en) * 2007-06-08 2010-07-08 Henry Joseph Horacek Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
CA3001337C (en) 2015-10-09 2023-12-12 Reckitt Benckiser Llc Pharmaceutical formulation
EP4285895A1 (en) 2022-06-03 2023-12-06 Adalvo Limited Nitrofurantoin oral dosage form

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL171628C (nl) * 1950-05-29 Inst Francais Du Petrole Inrichting voor het uitzenden van akoestische golven in een vloeibaar milieu.
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
US3427378A (en) * 1965-02-12 1969-02-11 American Cyanamid Co Sustained release encapsulated formula
GB1093286A (en) * 1965-02-15 1967-11-29 Biorex Laboratories Ltd Improvements in or relating to dosage unit forms for the administration of medicaments and diagnostic agents
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet
GB1204580A (en) * 1968-10-05 1970-09-09 Aspro Nicholas Ltd Pharmaceutical dosage forms
US3634584A (en) * 1969-02-13 1972-01-11 American Home Prod Sustained action dosage form
US3851051A (en) * 1970-07-17 1974-11-26 Scherer R Corp Soft gelatin capsule containing high water content fill
US4152444A (en) * 1972-04-19 1979-05-01 Ciba-Geigy Corporation Pharmaceutical compound preparations with bactericidal action
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
FR2287216A1 (fr) * 1974-10-09 1976-05-07 Narcisse Guy Nouvelle forme galenique d'administration de medicaments et medicaments prepares sous cette nouvelle forme
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
FR2407720A1 (fr) * 1977-11-08 1979-06-01 Lipha Lyonnaise Indle Pharmace Preparations pharmaceutiques orales a activite therapeutique prolongee
US4247552A (en) * 1979-01-11 1981-01-27 Syntex (U.S.A.) Inc. Contraceptive compositions and methods employing 1-substituted imidazole derivatives
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
IE63321B1 (en) * 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system

Also Published As

Publication number Publication date
DK306587D0 (da) 1987-06-16
JPS63258407A (ja) 1988-10-25
AU7421287A (en) 1987-12-17
ZA874315B (en) 1988-08-31
JPH0830007B2 (ja) 1996-03-27
CA1295247C (en) 1992-02-04
US4798725A (en) 1989-01-17
DE3772269D1 (de) 1991-09-26
ATA151587A (de) 1994-02-15
NZ220696A (en) 1990-08-28
PH25179A (en) 1991-03-27
AU589866B2 (en) 1989-10-19
EP0250038B1 (en) 1991-08-21
EP0250038A3 (en) 1989-01-18
AT398165B (de) 1994-10-25
EP0250038A2 (en) 1987-12-23
IL82806A0 (en) 1987-12-20
IE60586B1 (en) 1994-07-27
IE871584L (en) 1987-12-16
DK306587A (da) 1987-12-17

Similar Documents

Publication Publication Date Title
IL82806A (en) Sustained release capsules containing mixture of drug,polyvinyl pyrrolidone and carboxyvinyl polymer
IL81611A (en) N-cycloalkano(1,2-b)indole derivatives of aryl-sulfonamides,their preparation and medicaments containing them
AU6893287A (en) Sustained release pharmaceutical preparation
AU2219988A (en) Drug capsule
AU609390B2 (en) Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs
HK12395A (en) Formulation for preparing sustained release drugs for oral administration
AU7378987A (en) Drug delivery device, its preparation and use
HU893392D0 (en) Process for the preparation of peptides with t-cell helping activity and pharmaceutical compositions containing them
NZ220695A (en) Sustained release/rapid release (combined) pharmaceutical capsules containing nitrofurantoin
CY1923A (en) Carrier material for administration of drugs
EP0338820A3 (en) Heat sealable membrane for transdermal drug release
EP0237263A3 (en) Transdermal drug delivery system
IL81201A0 (en) Indole derivatives,their preparation and pharmaceutical compositions containing them
EP0237073A3 (en) Il-1alpha derivatives and drugs
AU7141087A (en) Pharmaceutical slow release tablets of etorphine
ZA862351B (en) Drug,preparation and use thereof
AU8164287A (en) 3-(w-(3,5-di-t-butyl-4-hydroxyphenyl)- alkanoyl)pyrroles, their de-oxy analogs, and therapeutic uses thereof
ZA871766B (en) Acetamide derivatives,their preparation and pharmaceutical compositions containing them
GB2089210B (en) Polymeric diffusion matrix for administration of drugs
IL81232A0 (en) Pharmaceutical composition with sustained release of the active component and a process for the preparation thereof
AR244756A1 (es) Nuevos monomeros y polimeros coloreados, procedimiento de preparacion de dichos polimeros y procedimiento de separacion de sustancias biologicamente activas mediante el uso de dichos polimeros.
AU7504987A (en) Novel tricyclic derivatives which are agonists of cholinergic receptors, and drugs in which they are present
ZA872739B (en) Benzimidazolesulfonamides and imidazopyridine-sulfonamides,their preparation and their application as drugs
IL92792A0 (en) Annelated indole derivatives,their preparation and pharmaceutical compositions containing them
GB8901833D0 (en) Pharmaceutical formulations with controlled drug release

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired